Palvella Therapeutics, Inc.
PVLA
$156.13
-$0.42-0.27%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 250.58M | 261.85M | 57.98M | 63.57M | 70.43M |
| Total Receivables | 400.00K | -- | -- | 2.22M | 1.98M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.04M | 1.38M | 1.01M | 1.15M | 1.34M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 253.03M | 263.23M | 58.99M | 66.94M | 73.75M |
|
|
|||||
| Total Current Assets | 253.03M | 263.23M | 58.99M | 66.94M | 73.75M |
| Net Property, Plant & Equipment | 482.00K | 528.00K | 572.00K | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 253.51M | 263.76M | 59.56M | 66.94M | 73.75M |
|
|
|||||
| Total Accounts Payable | 6.79M | 5.44M | 4.60M | 3.48M | 4.56M |
| Total Accrued Expenses | 3.70M | 2.50M | 3.65M | 3.56M | 2.16M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 217.00K | 209.00K | 202.00K | -- | -- |
| Total Finance Division Other Current Liabilities | 1.24M | 960.00K | 2.90M | 3.27M | 2.90M |
| Total Other Current Liabilities | 1.24M | 960.00K | 2.90M | 3.27M | 2.90M |
| Total Current Liabilities | 11.95M | 9.12M | 11.34M | 10.31M | 9.62M |
|
|
|||||
| Total Current Liabilities | 11.95M | 9.12M | 11.34M | 10.31M | 9.62M |
| Long-Term Debt | 22.11M | 19.80M | 17.76M | 16.02M | 14.51M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 318.00K | 375.00K | 431.00K | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.27M | 2.16M | 2.04M | 1.92M | 1.84M |
| Total Liabilities | 36.64M | 31.45M | 31.58M | 28.26M | 25.97M |
|
|
|||||
| Common Stock & APIC | 389.87M | 383.44M | 163.35M | 161.31M | 159.28M |
| Retained Earnings | -173.09M | -151.22M | -135.45M | -122.74M | -111.39M |
| Treasury Stock & Other | 89.00K | 95.00K | 83.00K | 104.00K | -111.00K |
| Total Common Equity | 216.87M | 232.31M | 27.98M | 38.68M | 47.78M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 216.87M | 232.31M | 27.98M | 38.68M | 47.78M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 216.87M | 232.31M | 27.98M | 38.68M | 47.78M |
|
|
|||||